MIM
ICPT

Macroview Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Macroview Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-137
Closed -$3K – 425
2020
Q4 		$3K Buy
137
+67
+96% +$2.22K ﹤0.01% 292
2020
Q3 		$3K Buy
70
+1
+1% +$46 0.01% 259
2020
Q2 		$3K Buy
+69
New +$5.33K 0.01% 245

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Macroview Investment Management's ICPT Position: Q1 2021 in Review

Macroview Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 137 shares — an estimated $3K sold.

Macroview Investment Management first reported a position in ICPT in Q2 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

  • Macroview Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Macroview Investment Management sold 137 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $3K.
  • Macroview Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2020 and held it in 3 quarters.
  • Macroview Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $3K in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Macroview Investment Management's 13F filing for Q1 2021, filed 3 May 2021.